Equity alert: rosen, skilled investor counsel, encourages bioxcel therapeutics, inc. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – btai

New york--(business wire)--why: rosen law firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of bioxcel therapeutics, inc. (nasdaq: btai) between december 15, 2021 and june 28, 2023, both dates inclusive (the “class period”). a class action lawsuit has already been filed. if you wish to serve as lead plaintiff, you must move the court no later than september 5, 2023. so what: if you purchased bioxcel therapeutics securit.
BTAI Ratings Summary
BTAI Quant Ranking